The Role of Matrix Metalloproteinase-9 in Lung Function Impairment in Patients with Post-Tuberculosis Sequelae
Jurnal Respirologi Indonesia · 2026
DOI: 10.36497/3chv8k81 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Respirologi Indonesia, 2026. Verfasst von Hetti Rusmini und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Post-tuberculosis (post-TB) sequelae are long-term pulmonary complications that persist despite completion of anti-tuberculosis treatment (ATT). These long-term effects frequently contribute to diminished pulmonary function and a lower quality of life. Matrix metalloproteinase-9 (MMP-9) is thought to be involved in the process of lung tissue injury among individuals recovering from tuberculosis. This study aimed to explore the correlation between serum MMP-9 levels and pulmonary function impairment in post-TB patients.
Methods
An observational case-control study was carried out at Dr. H. Abdul Moeloek Hospital in Lampung between April 2023 and March 2024. The study involved 35 post-TB patients (case group) and 35 healthy individuals (control group). Pulmonary function was evaluated using spirometry, while serum MMP-9 concentrations were measured by ELISA. The data were statistically analysed using the Mann-Whitney U test and Spearman's rank correlation.
Results
The post-TB group exhibited higher serum MMP-9 levels compared to the control group (1137.7±527.4 vs. 939.5±360.1), though the difference did not reach statistical significance. Post-TB patients showed reduced lung function, particularly in FEV1/FVC, FEV1, and FVC values. There was a significant correlation between MMP-9 levels and pulmonary function parameters, including pre-bronchodilator FEV1/FVC (r = -0.321; P=0.007), post-bronchodilator FEV1/FVC (r = -0.265; P=0.027), and %FEV1 (r = -0.254; P=0.034).
Conclusion
Increased serum MMP-9 levels are associated with reduced lung function in post-tuberculosis patients, particularly in cases of obstructive impairment. MMP-9 has the potential to be used as a biomarker for lung injury in individuals with a history of tuberculosis.
Zitieren
APA
Rusmini, H., Soemarwoto, R. A. S., Messah, A. D. V., Yunus, F., Dilangga, P., Herdarto, M. J. D., Hendarto, G. S., & Ekawati, D. (2026). The Role of Matrix Metalloproteinase-9 in Lung Function Impairment in Patients with Post-Tuberculosis Sequelae. Jurnal Respirologi Indonesia. https://doi.org/10.36497/3chv8k81
Vancouver
Rusmini H, Soemarwoto RAS, Messah ADV, Yunus F, Dilangga P, Herdarto MJD, et al. The Role of Matrix Metalloproteinase-9 in Lung Function Impairment in Patients with Post-Tuberculosis Sequelae. Jurnal Respirologi Indonesia. 2026. doi:10.36497/3chv8k81
BibTeX
@article{Rusmini2026,
author = {Rusmini, Hetti and Soemarwoto, Retno Ariza S and Messah, Anse Diana V and Yunus, Faisal and Dilangga, Pad and Herdarto, Muhammad Junus Didiek and Hendarto, Gatot Sudiro and Ekawati, Diyan},
title = {The Role of Matrix Metalloproteinase-9 in Lung Function Impairment in Patients with Post-Tuberculosis Sequelae},
journal = {Jurnal Respirologi Indonesia},
year = {2026},
doi = {10.36497/3chv8k81}
}
EUVIMED